Dr. Jeanne M Mase, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 331 E Falmouth Hwy, E Falmouth, MA 02536 Phone: 508-495-0704 Fax: 508-495-0293 |
News Archive
People who worry about cancer are more likely to want to get screened for colon cancer, but feeling uncomfortable at the thought of cancer makes them less likely to actually go for the test, finds new UCL-led research.
Revealing a biological combat strategy worthy of a five-star general, researchers from Houston Methodist Hospital, University of Chicago and Cornell University have shown how a cell surface receptor-a specialized protein which communicates signals between a cell and the outside world-can mobilize immune cells to attack, rather than protect, malignant tumors.
Acclarent, Inc. announced today that the U.S. Patent and Trademark Office awarded U.S. Patent Number 7,500,971, entitled "Devices, Systems and Methods for Treating Disorders of the Ear, Nose and Throat," to the company.
Chelsea Therapeutics International, Ltd. announced today that it has priced a public offering of approximately 7.14 million shares of its common stock at a price of $4.90 per share which will result in gross proceeds of $35 million. Net proceeds to the company, after underwriting discounts and commissions and expenses, will be approximately $32.8 million.
SEI today announced that one of the company's institutional clients - Meda Pharmaceuticals - was recognized with the "Solutions Superstar" award by EmployersWeb. The award honors Meda for their outstanding and innovative defined benefit plan management including asset allocation changes and strategies aimed at matching the duration of invested assets with the plan's liabilities.
› Verified 5 days ago